US Patent 8410047 Counteracting drug-induced obesity using GLP-1 agonists

Patent 8410047 was granted and assigned to Novo Nordisk on April, 2013 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Novo Nordisk

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

8410047

Date of Patent

April 2, 2013

Patent Application Number

11629238

Date Filed

May 31, 2005

Patent Citations Received

‌

US Patent 11957735 Releasable GLP-1 conjugates

‌

US Patent 11786599 Releasable conjugates

Patent Primary Examiner

‌

Gyan Chandra

Patent abstract

The present invention describes administering a GLP-1 agonist to treat obesity caused by the administration of an obesity-inducing drug.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 8410047 Counteracting drug-induced obesity using GLP-1 agonists

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API